"","Key performance property","Max","NA"
"1","SMC program coverage [70% - 100%]","CLINICAL INCIDENCE","17% to 48%"
"2","SMC program coverage [70% - 100%]","SEVERE DISEASE","35% to 60%"
"3","Duration of protection [10 - 60 days]","CLINICAL INCIDENCE","36% to 65%"
"4","Duration of protection [10 - 60 days]","SEVERE DISEASE","16% to 40%"
"5","SMC round coverage [70% - 100%]","CLINICAL INCIDENCE","11% to 18%"
"6","SMC round coverage [70% - 100%]","SEVERE DISEASE","15% to 27%"
"7","Initial efficacy [80% - 100%]","CLINICAL INCIDENCE","2% to 7%"
"8","Initial efficacy [80% - 100%]","SEVERE DISEASE","1% to 5%"
